A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention

Clinical trial NCT01617941 · WITHDRAWN

Trial details

NCT number: NCT01617941
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening

Start date: 2016-05-01
Primary completion: 2016-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.